Sign in to fuzzto save your conversations, follow your research and come back anytime.
Acutaas Chemicals
SectorHealthcare
Company insights, generated from the most recent coverage.
EPS CAGR of only 21% over FY26-29E cannot support a ~58x forward multiple; the gap between growth rate and valuation is what closes when sentiment turns.
HDFC Securities SELL note on Sep 21, 2026 with a ₹2,210 target implying ~36% downside was the main trigger for institutional selling in Acutaas Chemicals.
Post-record-date selling (final dividend ₹2.50/share, record date Sep 17) plus trading window closure ahead of Q2 FY27 results added mild sentiment pressure on the stock.
